Enveric Biosciences Inc vs ThredUp Inc — how do they compare? Enveric Biosciences Inc trades at $1.37 (market cap $5.32M), while ThredUp Inc trades at $6.69 (market cap $858.12M). The key difference: ThredUp Inc is far larger — about 161.3× Enveric Biosciences Inc's market cap, and ThredUp Inc is trading nearer its 52-week high, Enveric Biosciences Inc nearer its low. Which is the better fit depends on your goals.
| ENVB | TDUP | |
|---|---|---|
Market Cap | $5.32M | $858.12M |
Sector | Health | Consumer Cyclical |
52-Week High | $17.40 | $12.08 |
52-Week Low | $1.28 | $3.11 |
Enterprise Value | $408.82K | $860.86M |
Signals from Pluang's Aura AI — not financial advice
ENVB trades at $1.38, up 4.55% today, with a bearish technical signal from moving averages but neutral oscillators. The company reported a net loss of $8.77M for 2025, though it beat EPS estimates in all four quarters. Recent news highlights participation in investor conferences and progress with its neuroplastogen candidate EB-003, including IND-enabling studies and positive preclinical results.
Outlook hinges on clinical progress, with 75% analyst buy ratings supporting potential upside, but high financial losses and negative ROE/ROA pose significant risks. Investors face volatility from regulatory developments and funding needs, making it speculative despite positive sentiment from recent operational updates.
No Aura AI signal available yet.
Trailing returns across standard periods
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →ThredUp Inc is an online resale platform for women and kids apparel, shoes, and accessories. It generates revenue from items that are sold to buyers through the website, mobile app, and RaaS partners.
Read more on TDUP →